DT Investment Partners »

BioMarin Pharmaceutical shares owned by DT Investment Partners

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by DT Investment Partners from 13F filings

Historical chart of DT Investment Partners investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by DT Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by DT Investment Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 231 89.62
2023-09-30 $20k 231 88.48
2023-06-30 $21k 231 89.00
2023-03-31 $22k 231 96.98
2022-12-31 $24k 231 103.49
2022-09-30 $20k 231 86.58

More positions owned by DT Investment Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Intrm Gov Cr Etf (GVI)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Eafe Etf (EFA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Small Cp Etf (VB)
Dow (DOW)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Ishs 1-5yr Invs (IGSB)

View all positions for DT Investment Partners

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical